Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Philippe Nuss1,21Department of Psychiatry, Hôpital St Antoine, AP-HP, 2UMR 7203, INSERM ERL 1057 – Bioactive Molecules Laboratory, Pierre and Marie Curie University, Paris, FranceAbstract: Lines of evidence coming from many branches of neuroscience indicate that anxiety disorder...
Enregistré dans:
Auteur principal: | Nuss P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5de6aded5b584656a8a876f416b70aee |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Duloxetine in the treatment of generalized anxiety disorder
par: Trevor R Norman, et autres
Publié: (2009) -
The role of duloxetine in the treatment of anxiety disorders
par: Domenico De Berardis, et autres
Publié: (2008) -
Differential attentional bias in generalized anxiety disorder and panic disorder
par: Chen J, et autres
Publié: (2013) -
Pregabalin for the treatment of generalized anxiety disorder: an update
par: Baldwin DS, et autres
Publié: (2013) -
Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
par: Prasko J, et autres
Publié: (2016)